chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental underdose, Product administration error
Clinical narrative: received a dose of Moderna vial after vial had been punctured 20 times already; received a dose of Moderna vial after vial had been punctured 20 times already.; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (received a dose of Moderna vial after vial had been punctured 20 times already) and PRODUCT ADMINISTRATION ERROR (received a dose of Moderna vial after vial had been punctured 20 times already.) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Nov-2021 at 4:15 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Nov-2021, the patient experienced ACCIDENTAL UNDERDOSE (received a dose of Moderna vial after vial had been punctured 20 times already) and PRODUCT ADMINISTRATION ERROR (received a dose of Moderna vial after vial had been punctured 20 times already.). On 10-Nov-2021, ACCIDENTAL UNDERDOSE (received a dose of Moderna vial after vial had been punctured 20 times already) and PRODUCT ADMINISTRATION ERROR (received a dose of Moderna vial after vial had been punctured 20 times already.) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered ACCIDENTAL UNDERDOSE (received a dose of Moderna vial after vial had been punctured 20 times already) and PRODUCT ADMINISTRATION ERROR (received a dose of Moderna vial after vial had been punctured 20 times already.) to be not related.    No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-385918, MOD-2021-392369, MOD-2021-392379 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Myalgia
Clinical narrative: Took 6 days to get my energy back; Very bad body aches; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Took 6 days to get my energy back) and MYALGIA (Very bad body aches) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (hasn't been bad last year with the use of the mask.), Asthma (hasn't been bad last year with the use of the mask.) and Chronic bronchitis (had been good for two years). Concomitant products included CETIRIZINE for Allergy, VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced ASTHENIA (Took 6 days to get my energy back) and MYALGIA (Very bad body aches). On 24-Mar-2021, ASTHENIA (Took 6 days to get my energy back) had resolved. At the time of the report, MYALGIA (Very bad body aches) outcome was unknown.            No treatment information were provided.   This case was linked to MOD-2021-392250, MOD-2021-392574 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm very sore for 5 days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm very sore for 5 days) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017F21A) for COVID-19 vaccination.     Concurrent medical conditions included Egg allergy, Seasonal allergy and Hashimoto's disease. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Hashimoto's disease.    On 16-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Oct-2021, the patient experienced PAIN IN EXTREMITY (Arm very sore for 5 days). On 20-Oct-2021, PAIN IN EXTREMITY (Arm very sore for 5 days) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment medications were reported.   This case was linked to MOD-2021-392686 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: your vaccine is hurting people; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of VACCINATION COMPLICATION (your vaccine is hurting people) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (your vaccine is hurting people). At the time of the report, VACCINATION COMPLICATION (your vaccine is hurting people) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Myalgia, Oropharyngeal pain, Skin tightness
Clinical narrative: Started with cough; Sore throat; Headaches; Body aches,muscles were difficult to move; joints and muscles were difficult to move; skin a little tight everywhere; first day a little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE JOINT DISCOMFORT (joints and muscles were difficult to move), SKIN TIGHTNESS (skin a little tight everywhere), OROPHARYNGEAL PAIN (Sore throat), COUGH (Started with cough) and MYALGIA (Body aches,muscles were difficult to move) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 069F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma (hasn't been bad last year with the use of the mask.), Allergy (hasn't been bad last year with the use of the mask.) and Chronic bronchitis (has been good for two years). Concomitant products included CETIRIZINE for Allergy, VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 14-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Nov-2021, the patient experienced VACCINATION SITE PAIN (first day a little sore). On 15-Nov-2021, the patient experienced VACCINATION SITE JOINT DISCOMFORT (joints and muscles were difficult to move), SKIN TIGHTNESS (skin a little tight everywhere) and MYALGIA (Body aches,muscles were difficult to move). On 17-Nov-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headaches). On 19-Nov-2021, the patient experienced COUGH (Started with cough). On 17-Nov-2021, VACCINATION SITE JOINT DISCOMFORT (joints and muscles were difficult to move), SKIN TIGHTNESS (skin a little tight everywhere) and MYALGIA (Body aches,muscles were difficult to move) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), COUGH (Started with cough), VACCINATION SITE PAIN (first day a little sore) and HEADACHE (Headaches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was also a teacher with severe disabilities. She usually took a medication for Bronchitis, 6 doses, and she was good to go afterwards. Patient has inhaler but hasn't used it for two years.  Patient drank too much water with potassium and electrolytes and felt better. Patient reached out to her doctor  and was waiting for doctor to call back.   This case was linked to MOD-2021-392250, MOD-2021-392451 (Patient Link).; Sender's Comments: Non-serious case.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site joint discomfort, Vaccination site pain
Clinical narrative: Started with cough; Sore throat; Headaches; Body aches,muscles were difficult to move; joints and muscles were difficult to move; skin a little tight everywhere; first day a little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE JOINT DISCOMFORT (joints and muscles were difficult to move), SKIN TIGHTNESS (skin a little tight everywhere), OROPHARYNGEAL PAIN (Sore throat), COUGH (Started with cough) and MYALGIA (Body aches,muscles were difficult to move) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 069F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma (hasn't been bad last year with the use of the mask.), Allergy (hasn't been bad last year with the use of the mask.) and Chronic bronchitis (has been good for two years). Concomitant products included CETIRIZINE for Allergy, VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 14-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Nov-2021, the patient experienced VACCINATION SITE PAIN (first day a little sore). On 15-Nov-2021, the patient experienced VACCINATION SITE JOINT DISCOMFORT (joints and muscles were difficult to move), SKIN TIGHTNESS (skin a little tight everywhere) and MYALGIA (Body aches,muscles were difficult to move). On 17-Nov-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headaches). On 19-Nov-2021, the patient experienced COUGH (Started with cough). On 17-Nov-2021, VACCINATION SITE JOINT DISCOMFORT (joints and muscles were difficult to move), SKIN TIGHTNESS (skin a little tight everywhere) and MYALGIA (Body aches,muscles were difficult to move) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), COUGH (Started with cough), VACCINATION SITE PAIN (first day a little sore) and HEADACHE (Headaches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was also a teacher with severe disabilities. She usually took a medication for Bronchitis, 6 doses, and she was good to go afterwards. Patient has inhaler but hasn't used it for two years.  Patient drank too much water with potassium and electrolytes and felt better. Patient reached out to her doctor  and was waiting for doctor to call back.   This case was linked to MOD-2021-392250, MOD-2021-392451 (Patient Link).; Sender's Comments: Non-serious case.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter No treatment information was provided by the reporter
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product administration error
Clinical narrative: error resulting in administration of expired vaccine; Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTRATION ERROR (error resulting in administration of expired vaccine) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Aug-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (error resulting in administration of expired vaccine) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 27-Aug-2021, PRODUCT ADMINISTRATION ERROR (error resulting in administration of expired vaccine) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported No Treatment medications reported
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.   Some of patient received booster dose on 1-Nov-2021, 05-Nov-2021, 11-Nov-2021 and 12-Nov-2021. No vial went any temperature excursions.   Most recent FOLLOW-UP information incorporated above includes: On 19-Nov-2021: Follow up received, Reporter information updated, Dose administration details updated.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vials were used to provide 38 doses; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vials were used to provide 38 doses) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vials were used to provide 38 doses). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vials were used to provide 38 doses) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.  No vial went any temperature excursions.   Most recent FOLLOW-UP information incorporated above includes: On 19-Nov-2021: Non Significant Follow Up Appended with Second reporter Information in case
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: she had side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (she had side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (she had side effects). At the time of the report, VACCINATION COMPLICATION (she had side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was provided by the reporter. No treatment medications was provided by the reporter.  This is a spontaneous case concerning a female patient of unknown age with no relevant medical history, who experienced the unexpected, non serious event of vaccination complication. The event vaccination complication (unspecified) occurrence unknown with respect to the unknown dose number of mRNA-1273 vaccine. The rechallenge was not applicable since the only information disclosed was with this unknown dose number. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 19-Nov-2021: follow-up received contain no significant information; Sender's Comments: This is a spontaneous case concerning a female patient of unknown age with no relevant medical history, who experienced the unexpected, non serious event of vaccination complication. The event vaccination complication (unspecified) occurrence unknown with respect to the unknown dose number of mRNA-1273 vaccine. The rechallenge was not applicable since the only information disclosed was with this unknown dose number. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Age: 56.0
Sex: U
Vaccine: COVID19
Symptoms: Death
Clinical narrative: The patient passed away; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (The patient passed away) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Death occurred on 01-Nov-2021 The patient died on 01-Nov-2021. The cause of death was not reported. It is unknown if an autopsy was performed.            No concomitant medication reported. No Treatment Medication reported.  Company comment This is a spontaneous case concerning a 56-year-old male patient with no relevant medical history reported, who experienced serious, unexpected event of death. The event occurred on an unknown date after receiving a dose of mRNA-1273 vaccine. The patient died on 01-Nov-2021. The cause of death was not reported. It is unknown if an autopsy was performed.  Very limited information regarding this event has been provided at this time. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a 56-year-old male patient with no relevant medical history reported, who experienced serious, unexpected event of death. The event occurred on an unknown date after receiving a dose of mRNA-1273 vaccine. The patient died on 01-Nov-2021. The cause of death was not reported. It is unknown if an autopsy was performed.  Very limited information regarding this event has been provided at this time. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Reported Cause(s) of Death: Unknown cause of death
Sex: F
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: Received dose from a vial punctured more than 20 times; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Received dose from a vial punctured more than 20 times) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Nov-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Received dose from a vial punctured more than 20 times). On 19-Nov-2021, PRODUCT ADMINISTRATION ERROR (Received dose from a vial punctured more than 20 times) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information provided.   This case was linked to MOD-2021-393508 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication were provided   Most recent FOLLOW-UP information incorporated above includes: On 19-Nov-2021: Follow Up received contains no significant information.; Sender's Comments: Case is non-serious no CC needed
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitants medication were provided.  No treatment medication were provided.   This case was linked to MOD-2021-393535, MOD-2021-393537 (Patient Link).
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037F21A, 017B21A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.            Concomitant products were not provided. Treatment medication were not reported.   This case was linked to MOD-2021-393534, MOD-2021-393535 (Patient Link).
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Feeling abnormal
Clinical narrative: felt blegh; 24 hours of no energy; tired/ really fatigued/ wiped out from booster dose; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt blegh), ASTHENIA (24 hours of no energy) and FATIGUE (tired/ really fatigued/ wiped out from booster dose) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017F21A, 013M20A and 025L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (felt blegh), ASTHENIA (24 hours of no energy) and FATIGUE (tired/ really fatigued/ wiped out from booster dose). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (felt blegh), ASTHENIA (24 hours of no energy) and FATIGUE (tired/ really fatigued/ wiped out from booster dose) outcome was unknown.            Concomitant product included Blood pressure medicine and Diuretic.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Dysuria, Headache
Clinical narrative: My daughter is experiencing a headache  centralized to the lower right of back of head by her neck. She woke up to tonight to go pee because she had the sensation to go pee, but she is unable to go pee. We had been up for a couple hours complaining that she needs to pee but cannot.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood culture negative, Blood lactic acid increased, Body temperature increased, Brain natriuretic peptide increased
Clinical narrative: Patient currently inpatient  at (5) days admission on 11/21/21.  Patient is a 68 y.o. male who presents today with significant worsening dyspnea, shortness of breath, hypoxemia, and pain from previous rib fractures.   Patient fell last Tuesday on November 18th in presented to emergency department is noted to have rib fractures to 8th and 9th rib on the right side.  Patient has history of chronic obstructive pulmonary disease and severe emphysema.  He was sent home with narcotic pain management including oxycodone Zanaflex.  Apparently states this was not helping.   Patient presented back to the emergency department today with worsening rib pain worsening shortness of breath.  At home he usually takes 2 L of home oxygen only at night.  He arrived without oxygen with his saturations at 70%.  He was placed on high-flow nasal cannula at that time.  It was noted he had elevated BNP, procalcitonin, and lactic acid.  He was given IV fluid bolus of 2 L. COVID test was noted to be positive.  Patient has been vaccinated.  Chest x-ray revealed interstitial changes with possible pneumonia versus emphysematous change.  He was given IV Levaquin in the emergency department as well as Dilaudid for pain.  Also given Tylenol for low-grade temperature blood cultures were taken.  Blood pressure was somewhat low so he was started on Levophed at that time.  Attempt was made to transfer patient due to the acuity of care but they were unable to transfer due to no bed availability.   Patient's chronic medical issues include the following hypertension, diet-controlled diabetes, history of pulmonary fibrosis, rheumatoid arthritis, obesity, coronary artery disease, chronic obstructive pulmonary disease with home oxygen 2 L, progressively worsening rib pain and progressive shortness of breath.   Patient admitted to intensive care unit with severe sepsis, bacterial pneumonia, acute respiratory failure with hypoxemia, and hypotension.  Currently on norepinephrine will wean down as appropriate.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiomegaly, Central venous catheterisation, Chest X-ray abnormal, Computerised tomogram thorax abnormal
Clinical narrative: Patient currently inpatient  at (5) days admission on 11/21/21.  Patient is a 68 y.o. male who presents today with significant worsening dyspnea, shortness of breath, hypoxemia, and pain from previous rib fractures.   Patient fell last Tuesday on November 18th in presented to emergency department is noted to have rib fractures to 8th and 9th rib on the right side.  Patient has history of chronic obstructive pulmonary disease and severe emphysema.  He was sent home with narcotic pain management including oxycodone Zanaflex.  Apparently states this was not helping.   Patient presented back to the emergency department today with worsening rib pain worsening shortness of breath.  At home he usually takes 2 L of home oxygen only at night.  He arrived without oxygen with his saturations at 70%.  He was placed on high-flow nasal cannula at that time.  It was noted he had elevated BNP, procalcitonin, and lactic acid.  He was given IV fluid bolus of 2 L. COVID test was noted to be positive.  Patient has been vaccinated.  Chest x-ray revealed interstitial changes with possible pneumonia versus emphysematous change.  He was given IV Levaquin in the emergency department as well as Dilaudid for pain.  Also given Tylenol for low-grade temperature blood cultures were taken.  Blood pressure was somewhat low so he was started on Levophed at that time.  Attempt was made to transfer patient due to the acuity of care but they were unable to transfer due to no bed availability.   Patient's chronic medical issues include the following hypertension, diet-controlled diabetes, history of pulmonary fibrosis, rheumatoid arthritis, obesity, coronary artery disease, chronic obstructive pulmonary disease with home oxygen 2 L, progressively worsening rib pain and progressive shortness of breath.   Patient admitted to intensive care unit with severe sepsis, bacterial pneumonia, acute respiratory failure with hypoxemia, and hypotension.  Currently on norepinephrine will wean down as appropriate.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Culture urine, Dyspnoea, Echocardiogram, Echocardiogram abnormal
Clinical narrative: Patient currently inpatient  at (5) days admission on 11/21/21.  Patient is a 68 y.o. male who presents today with significant worsening dyspnea, shortness of breath, hypoxemia, and pain from previous rib fractures.   Patient fell last Tuesday on November 18th in presented to emergency department is noted to have rib fractures to 8th and 9th rib on the right side.  Patient has history of chronic obstructive pulmonary disease and severe emphysema.  He was sent home with narcotic pain management including oxycodone Zanaflex.  Apparently states this was not helping.   Patient presented back to the emergency department today with worsening rib pain worsening shortness of breath.  At home he usually takes 2 L of home oxygen only at night.  He arrived without oxygen with his saturations at 70%.  He was placed on high-flow nasal cannula at that time.  It was noted he had elevated BNP, procalcitonin, and lactic acid.  He was given IV fluid bolus of 2 L. COVID test was noted to be positive.  Patient has been vaccinated.  Chest x-ray revealed interstitial changes with possible pneumonia versus emphysematous change.  He was given IV Levaquin in the emergency department as well as Dilaudid for pain.  Also given Tylenol for low-grade temperature blood cultures were taken.  Blood pressure was somewhat low so he was started on Levophed at that time.  Attempt was made to transfer patient due to the acuity of care but they were unable to transfer due to no bed availability.   Patient's chronic medical issues include the following hypertension, diet-controlled diabetes, history of pulmonary fibrosis, rheumatoid arthritis, obesity, coronary artery disease, chronic obstructive pulmonary disease with home oxygen 2 L, progressively worsening rib pain and progressive shortness of breath.   Patient admitted to intensive care unit with severe sepsis, bacterial pneumonia, acute respiratory failure with hypoxemia, and hypotension.  Currently on norepinephrine will wean down as appropriate.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Ejection fraction decreased, Emphysema, Endotracheal intubation, Fall, Gastrointestinal tube insertion
Clinical narrative: Patient currently inpatient  at (5) days admission on 11/21/21.  Patient is a 68 y.o. male who presents today with significant worsening dyspnea, shortness of breath, hypoxemia, and pain from previous rib fractures.   Patient fell last Tuesday on November 18th in presented to emergency department is noted to have rib fractures to 8th and 9th rib on the right side.  Patient has history of chronic obstructive pulmonary disease and severe emphysema.  He was sent home with narcotic pain management including oxycodone Zanaflex.  Apparently states this was not helping.   Patient presented back to the emergency department today with worsening rib pain worsening shortness of breath.  At home he usually takes 2 L of home oxygen only at night.  He arrived without oxygen with his saturations at 70%.  He was placed on high-flow nasal cannula at that time.  It was noted he had elevated BNP, procalcitonin, and lactic acid.  He was given IV fluid bolus of 2 L. COVID test was noted to be positive.  Patient has been vaccinated.  Chest x-ray revealed interstitial changes with possible pneumonia versus emphysematous change.  He was given IV Levaquin in the emergency department as well as Dilaudid for pain.  Also given Tylenol for low-grade temperature blood cultures were taken.  Blood pressure was somewhat low so he was started on Levophed at that time.  Attempt was made to transfer patient due to the acuity of care but they were unable to transfer due to no bed availability.   Patient's chronic medical issues include the following hypertension, diet-controlled diabetes, history of pulmonary fibrosis, rheumatoid arthritis, obesity, coronary artery disease, chronic obstructive pulmonary disease with home oxygen 2 L, progressively worsening rib pain and progressive shortness of breath.   Patient admitted to intensive care unit with severe sepsis, bacterial pneumonia, acute respiratory failure with hypoxemia, and hypotension.  Currently on norepinephrine will wean down as appropriate.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Hypoxia, Inspiratory capacity decreased, Intensive care, Interstitial lung disease
Clinical narrative: Patient currently inpatient  at (5) days admission on 11/21/21.  Patient is a 68 y.o. male who presents today with significant worsening dyspnea, shortness of breath, hypoxemia, and pain from previous rib fractures.   Patient fell last Tuesday on November 18th in presented to emergency department is noted to have rib fractures to 8th and 9th rib on the right side.  Patient has history of chronic obstructive pulmonary disease and severe emphysema.  He was sent home with narcotic pain management including oxycodone Zanaflex.  Apparently states this was not helping.   Patient presented back to the emergency department today with worsening rib pain worsening shortness of breath.  At home he usually takes 2 L of home oxygen only at night.  He arrived without oxygen with his saturations at 70%.  He was placed on high-flow nasal cannula at that time.  It was noted he had elevated BNP, procalcitonin, and lactic acid.  He was given IV fluid bolus of 2 L. COVID test was noted to be positive.  Patient has been vaccinated.  Chest x-ray revealed interstitial changes with possible pneumonia versus emphysematous change.  He was given IV Levaquin in the emergency department as well as Dilaudid for pain.  Also given Tylenol for low-grade temperature blood cultures were taken.  Blood pressure was somewhat low so he was started on Levophed at that time.  Attempt was made to transfer patient due to the acuity of care but they were unable to transfer due to no bed availability.   Patient's chronic medical issues include the following hypertension, diet-controlled diabetes, history of pulmonary fibrosis, rheumatoid arthritis, obesity, coronary artery disease, chronic obstructive pulmonary disease with home oxygen 2 L, progressively worsening rib pain and progressive shortness of breath.   Patient admitted to intensive care unit with severe sepsis, bacterial pneumonia, acute respiratory failure with hypoxemia, and hypotension.  Currently on norepinephrine will wean down as appropriate.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Legionella test, Lung opacity, Musculoskeletal chest pain, Pericardial effusion, Pneumonia bacterial
Clinical narrative: Patient currently inpatient  at (5) days admission on 11/21/21.  Patient is a 68 y.o. male who presents today with significant worsening dyspnea, shortness of breath, hypoxemia, and pain from previous rib fractures.   Patient fell last Tuesday on November 18th in presented to emergency department is noted to have rib fractures to 8th and 9th rib on the right side.  Patient has history of chronic obstructive pulmonary disease and severe emphysema.  He was sent home with narcotic pain management including oxycodone Zanaflex.  Apparently states this was not helping.   Patient presented back to the emergency department today with worsening rib pain worsening shortness of breath.  At home he usually takes 2 L of home oxygen only at night.  He arrived without oxygen with his saturations at 70%.  He was placed on high-flow nasal cannula at that time.  It was noted he had elevated BNP, procalcitonin, and lactic acid.  He was given IV fluid bolus of 2 L. COVID test was noted to be positive.  Patient has been vaccinated.  Chest x-ray revealed interstitial changes with possible pneumonia versus emphysematous change.  He was given IV Levaquin in the emergency department as well as Dilaudid for pain.  Also given Tylenol for low-grade temperature blood cultures were taken.  Blood pressure was somewhat low so he was started on Levophed at that time.  Attempt was made to transfer patient due to the acuity of care but they were unable to transfer due to no bed availability.   Patient's chronic medical issues include the following hypertension, diet-controlled diabetes, history of pulmonary fibrosis, rheumatoid arthritis, obesity, coronary artery disease, chronic obstructive pulmonary disease with home oxygen 2 L, progressively worsening rib pain and progressive shortness of breath.   Patient admitted to intensive care unit with severe sepsis, bacterial pneumonia, acute respiratory failure with hypoxemia, and hypotension.  Currently on norepinephrine will wean down as appropriate.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Procalcitonin increased, Rib fracture, SARS-CoV-2 test positive, Scan with contrast abnormal, Sepsis
Clinical narrative: Patient currently inpatient  at (5) days admission on 11/21/21.  Patient is a 68 y.o. male who presents today with significant worsening dyspnea, shortness of breath, hypoxemia, and pain from previous rib fractures.   Patient fell last Tuesday on November 18th in presented to emergency department is noted to have rib fractures to 8th and 9th rib on the right side.  Patient has history of chronic obstructive pulmonary disease and severe emphysema.  He was sent home with narcotic pain management including oxycodone Zanaflex.  Apparently states this was not helping.   Patient presented back to the emergency department today with worsening rib pain worsening shortness of breath.  At home he usually takes 2 L of home oxygen only at night.  He arrived without oxygen with his saturations at 70%.  He was placed on high-flow nasal cannula at that time.  It was noted he had elevated BNP, procalcitonin, and lactic acid.  He was given IV fluid bolus of 2 L. COVID test was noted to be positive.  Patient has been vaccinated.  Chest x-ray revealed interstitial changes with possible pneumonia versus emphysematous change.  He was given IV Levaquin in the emergency department as well as Dilaudid for pain.  Also given Tylenol for low-grade temperature blood cultures were taken.  Blood pressure was somewhat low so he was started on Levophed at that time.  Attempt was made to transfer patient due to the acuity of care but they were unable to transfer due to no bed availability.   Patient's chronic medical issues include the following hypertension, diet-controlled diabetes, history of pulmonary fibrosis, rheumatoid arthritis, obesity, coronary artery disease, chronic obstructive pulmonary disease with home oxygen 2 L, progressively worsening rib pain and progressive shortness of breath.   Patient admitted to intensive care unit with severe sepsis, bacterial pneumonia, acute respiratory failure with hypoxemia, and hypotension.  Currently on norepinephrine will wean down as appropriate.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Streptococcus test negative
Clinical narrative: Patient currently inpatient  at (5) days admission on 11/21/21.  Patient is a 68 y.o. male who presents today with significant worsening dyspnea, shortness of breath, hypoxemia, and pain from previous rib fractures.   Patient fell last Tuesday on November 18th in presented to emergency department is noted to have rib fractures to 8th and 9th rib on the right side.  Patient has history of chronic obstructive pulmonary disease and severe emphysema.  He was sent home with narcotic pain management including oxycodone Zanaflex.  Apparently states this was not helping.   Patient presented back to the emergency department today with worsening rib pain worsening shortness of breath.  At home he usually takes 2 L of home oxygen only at night.  He arrived without oxygen with his saturations at 70%.  He was placed on high-flow nasal cannula at that time.  It was noted he had elevated BNP, procalcitonin, and lactic acid.  He was given IV fluid bolus of 2 L. COVID test was noted to be positive.  Patient has been vaccinated.  Chest x-ray revealed interstitial changes with possible pneumonia versus emphysematous change.  He was given IV Levaquin in the emergency department as well as Dilaudid for pain.  Also given Tylenol for low-grade temperature blood cultures were taken.  Blood pressure was somewhat low so he was started on Levophed at that time.  Attempt was made to transfer patient due to the acuity of care but they were unable to transfer due to no bed availability.   Patient's chronic medical issues include the following hypertension, diet-controlled diabetes, history of pulmonary fibrosis, rheumatoid arthritis, obesity, coronary artery disease, chronic obstructive pulmonary disease with home oxygen 2 L, progressively worsening rib pain and progressive shortness of breath.   Patient admitted to intensive care unit with severe sepsis, bacterial pneumonia, acute respiratory failure with hypoxemia, and hypotension.  Currently on norepinephrine will wean down as appropriate.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal wall oedema, Aortic arteriosclerosis, Atelectasis, Blood culture positive, Blood electrolytes normal
Clinical narrative: Patient discharged from (11) day inpatient stay from 11/12/2021-11/23/2021.  Patient was admitted through the emergency room with sepsis.  COVID positive.  Due to severity of his illness see was placed on remdesivir and Decadron also empiric antibiotic therapy.  Blood cultures were drawn and came back positive although they were polymicrobial as suspected overall contaminant.  Despite that he was continued on IV antibiotics along with the antivirals.  He was recovering from the COVID developed a increase in lactic acid was given fluids and continued with antibiotics a work broadened.  Responded quickly to that therapy.  He was doing well at the time of his discharge at discharge is white count was normal hemoglobin was stable at 12. 3. His lactic acid was normal at discharge his electrolytes were normal chest x-ray did show evidence of an infiltrate which probably should be repeated in about a week or 2 clinically he did not have evidence of bacterial pneumonia.  I suspect this is residual from his COVID infection.  He is at high risk for aspiration so will discharge him on Augmentin to complete his therapy.   Patient was seen by PT and OT.  In addition he was seen by General surgery regarding a decubitus.  He did not feel that this was the site of infection the area looked relatively clean.   Patient will be discharged to extended care facility
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid increased, COVID-19, Cardiomegaly, Chest X-ray abnormal, Computerised tomogram abdomen abnormal
Clinical narrative: Patient discharged from (11) day inpatient stay from 11/12/2021-11/23/2021.  Patient was admitted through the emergency room with sepsis.  COVID positive.  Due to severity of his illness see was placed on remdesivir and Decadron also empiric antibiotic therapy.  Blood cultures were drawn and came back positive although they were polymicrobial as suspected overall contaminant.  Despite that he was continued on IV antibiotics along with the antivirals.  He was recovering from the COVID developed a increase in lactic acid was given fluids and continued with antibiotics a work broadened.  Responded quickly to that therapy.  He was doing well at the time of his discharge at discharge is white count was normal hemoglobin was stable at 12. 3. His lactic acid was normal at discharge his electrolytes were normal chest x-ray did show evidence of an infiltrate which probably should be repeated in about a week or 2 clinically he did not have evidence of bacterial pneumonia.  I suspect this is residual from his COVID infection.  He is at high risk for aspiration so will discharge him on Augmentin to complete his therapy.   Patient was seen by PT and OT.  In addition he was seen by General surgery regarding a decubitus.  He did not feel that this was the site of infection the area looked relatively clean.   Patient will be discharged to extended care facility
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Decubitus ulcer, Dyspnoea, Gastric dilatation, Granulomatous liver disease
Clinical narrative: Patient discharged from (11) day inpatient stay from 11/12/2021-11/23/2021.  Patient was admitted through the emergency room with sepsis.  COVID positive.  Due to severity of his illness see was placed on remdesivir and Decadron also empiric antibiotic therapy.  Blood cultures were drawn and came back positive although they were polymicrobial as suspected overall contaminant.  Despite that he was continued on IV antibiotics along with the antivirals.  He was recovering from the COVID developed a increase in lactic acid was given fluids and continued with antibiotics a work broadened.  Responded quickly to that therapy.  He was doing well at the time of his discharge at discharge is white count was normal hemoglobin was stable at 12. 3. His lactic acid was normal at discharge his electrolytes were normal chest x-ray did show evidence of an infiltrate which probably should be repeated in about a week or 2 clinically he did not have evidence of bacterial pneumonia.  I suspect this is residual from his COVID infection.  He is at high risk for aspiration so will discharge him on Augmentin to complete his therapy.   Patient was seen by PT and OT.  In addition he was seen by General surgery regarding a decubitus.  He did not feel that this was the site of infection the area looked relatively clean.   Patient will be discharged to extended care facility